Pulmonx has secured a $60 million senior secured term loan from Perceptive, drawing $40 million at closing, which replaces its prior facility and provides increased liquidity alongside access to additional tranches tied to revenue milestones. Despite this financial maneuver, shares of Pulmonx dropped 5.88%. The new credit facility extends the company’s debt maturity to 2031 and allows for interest-only payments, as Pulmonx has also executed a cost restructuring initiative to streamline its ongoing operating expenses. This financing coincides with the release of Pulmonx’s fourth quarter and full year 2025 financial results.
Pulmonx secures $60M loan from Perceptive Advisors, shares drop 5.88%
